PT-141 for women dosage is a fixed 1.75 mg injection given at least 45 minutes before sex, once per 24 hours, up to a maximum of 8 doses per month.
The FDA-approved PT-141 for women dosage is 1.75 mg injected under the skin at least 45 minutes before anticipated sexual activity. One dose is allowed in any 24-hour period, with a maximum of eight doses per month. PT-141 (bremelanotide) is sold in the United States as the brand-name auto-injector Vyleesi, and it is approved only for premenopausal women with hypoactive sexual desire disorder (HSDD).
That dose is fixed. It does not change with body weight, age, or how well the first injection seemed to work, so the pt-141 peptide for women dosage is the same for essentially everyone who receives a prescription.
PT-141 for Women Dosage at a Glance
Every figure below comes from the FDA-approved product label. The prescription version of pt 141 for women is a single-use auto-injector, not a vial you measure yourself.
| Dose parameter | FDA-approved guidance |
|---|---|
| Amount per dose | 1.75 mg (0.3 mL) prefilled auto-injector |
| Route | Subcutaneous injection into the abdomen or thigh |
| Timing | At least 45 minutes before anticipated sexual activity |
| Maximum frequency | One dose in any 24-hour period |
| Monthly limit | No more than 8 doses per month |
| Dose adjustments | None — no titration and no weight-based changes |
| Approved population | Premenopausal women with HSDD |
How the Approved Dose Is Used in Practice
PT-141 is not a daily medication, and it is not taken on a schedule. It is used on demand, shortly before sex is expected, and only when the user is willing to accept the possibility of side effects such as nausea.
- Plan ahead: inject at least 45 minutes before sexual activity, not after.
- Rotate sites: alternate between the abdomen and the thigh, avoiding skin that is irritated or bruised.
- Do not stack doses: a second injection on the same day is outside the label.
- Track your month: eight doses per month is the ceiling, even if more opportunities arise.
- Reassess at eight weeks: the label advises stopping if there is no improvement in sexual desire after eight weeks of use.
Why There Is No PT-141 Dosage Calculator for Women
There is no validated pt-141 dosage calculator for women, because the approved product comes in one strength and requires no math. Weight-based dosing tools that circulate online are copied from unrelated peptides and do not reflect the bremelanotide label.
Searches for pt-141 10mg dosage women usually lead to peptide vendor pages, where the "10 mg" refers to the size of a vial of powder rather than a 10 mg dose. A 10 mg dose would be roughly five to six times the FDA-approved amount, which is why that number should never be treated as an instruction.
Powdered bremelanotide sold online is marketed for laboratory research. These products are not reviewed by the FDA for purity, sterility, or actual content, and the pt-141 dosage for men listed on the same pages has no regulatory basis either. The pt-141 dosage for men is unestablished because the drug is not approved for male use in the United States.
PT-141 Dosage for Women vs. Men
Men sometimes use bremelanotide off-label after obtaining a prescription from a clinician, but no male dose has been approved.
| Comparison point | Women | Men |
|---|---|---|
| FDA approval status | Approved for premenopausal HSDD | Not approved |
| Labeled dose | 1.75 mg subcutaneously | No labeled dose |
| Doses seen in published trials | 1.75 mg subcutaneously | Approximately 1.75–2 mg subcutaneously in small studies |
| Earlier development | Not applicable | Nasal spray formulations studied years ago for erectile dysfunction |
| Maximum frequency | 8 doses per month | Not defined by any label |
PT-141 for Women Side Effects and Safety
The most commonly reported pt-141 for women side effects are nausea, flushing, and headache. Nausea is the single most frequent complaint and often shows up with the first dose, though it can occur at any time.
- Nausea, sometimes with vomiting
- Flushing of the face, neck, or chest
- Headache
- Injection-site reactions such as pain, redness, or irritation
- Temporary increases in blood pressure and small, short-lived changes in heart rate
PT-141 is contraindicated in women with uncontrolled high blood pressure or known cardiovascular disease. Blood pressure should be under control before a prescription is started, and any history of heart problems should be discussed with the prescriber first.
Alcohol can make nausea and dizziness worse, so ask your clinician what limits are appropriate for you. PT-141 does not prevent pregnancy or sexually transmitted infections.
What to Ask Your Prescriber Before Starting
Bremelanotide is a prescription treatment, not a supplement, and it does not work for every woman who tries it. It is also not a hormone and does not address relationship stress, medication side effects, or other contributors to low desire.
- Is my blood pressure safe for this medication?
- What should I do if nausea is severe?
- How many doses per month fit my situation?
- How will we judge whether it is working after eight weeks?
Anyone considering a compounded or research-grade version should weigh the lack of quality oversight. The FDA-approved auto-injector exists so that the 1.75 mg dose is measured accurately every time, which is difficult to replicate with a syringe and a powder vial.
The Bottom Line
The PT-141 dosage for women is 1.75 mg by subcutaneous injection at least 45 minutes before sex, limited to one dose per 24 hours and eight doses per month. PT-141 is approved only for premenopausal women with HSDD, and it is not approved for men or for postmenopausal women. Anyone with uncontrolled hypertension or cardiovascular disease should not use it.
Frequently Asked Questions
What is the correct PT-141 dosage for women?
The FDA-approved dose is 1.75 mg injected under the skin of the abdomen or thigh at least 45 minutes before sexual activity. There is no titration and no weight-based adjustment, so the dose stays the same for every user. It is approved only for premenopausal women with hypoactive sexual desire disorder.
How often can women use PT-141?
You can use one dose in any 24-hour period and no more than eight doses in a month. If there is no improvement in sexual desire after eight weeks of use, the label advises discontinuing the medication. Using it more often than the label allows increases the chance of nausea, flushing, and blood pressure changes.
Is PT-141 available over the counter?
No. Bremelanotide is a prescription-only product sold as the Vyleesi auto-injector, and it requires a clinician's evaluation before use. Powdered bremelanotide sold by online peptide vendors is marketed for laboratory research only and is not FDA-approved for human use, so its purity and dose accuracy are not guaranteed.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.